VxP Pharma offers a complete range of in-vivo and in-vitro preclinical safety evaluation studies as part of our drug discovery and development services. Our preclinical staff is committed to providing flexible solutions, accelerated timelines and supporting GLP laboratory services that meet or exceed global regulatory standards/guidelines. We have conducted multiple IND and NDA enabling studies for submission to the US FDA and other global regulatory authorities.
- Acute / Sub-chronic / Chronic Toxicology
- Dose Range Finding (DRF)
- Development & Reproductive Toxicology (DART)
- Dermal Toxicology
- Ocular/Ophthalmic Toxicology
- Pathology/Clinical Pathology
Other Laboratory Services
- DMPK/ADME Studies (in-vivo/in-vitro)
- Medical Device Biocompatibility
- Cell Line Engineering & Gene Modification
At VxP Pharma, we understand your preclinical needs, and we have extensive experience working with the FDA, USDA, and EPA as required to make your animal research projects a success. Our tailored, individual study designs enable clients to meet their product development goals and facilitate world-wide regulatory approval. Our individualized approach with every study allows us to adapt to the evolving needs of your program. Our analytical support is second to none, so regardless of what your endpoint might be, VxP can help you get there.
Our state-of-the-art labs are staffed by some of the best trained and most experienced subject matter experts in the field.